BrainStorm
Subscribe on your favorite player
Listen on Apple Podcasts Listen on Spotify Listen on Stitcher Listen on Google PodcastsAmy Dockser Marcus, Author of "We the Scientists" (part 2)
Amy Dockser Marcus, Author of "We the Scientists" (part 2)
We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine
In Part 2 of the interview with Amy Dockser Marcus, Pulitzer Prize winning Wall Street Reporter and Author, she and host Meryl Comer discuss a rare disease often likened to Children’s Alzheimer’s. The common thread is advancing the science with new pathways for treating disease and conducting research. Amy talks about if this new collaborative research model aimed at saving children would work for elderly populations with long-term chronic diseases like Alzheimer’s. In the process to accelerate new drug development, science may be forever changed.
This episode is sponsored by Genentech and Eisai.
If you have recommendations for topics or guests, email us at [email protected]. To learn more go to: https://www.usagainstalzheimers.org/
About This Episode
We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine
In Part 2 of the interview with Amy Dockser Marcus, Pulitzer Prize winning Wall Street Reporter and Author, she and host Meryl Comer discuss a rare disease often likened to Children’s Alzheimer’s. The common thread is advancing the science with new pathways for treating disease and conducting research. Amy talks about if this new collaborative research model aimed at saving children would work for elderly populations with long-term chronic diseases like Alzheimer’s. In the process to accelerate new drug development, science may be forever changed.
This episode is sponsored by Genentech and Eisai.
If you have recommendations for topics or guests, email us at [email protected]. To learn more go to: https://www.usagainstalzheimers.org/